Back to companies
TENAX THERAPEUTICS, INC.
TENXUSNASDAQPharmaceuticals & HealthcareTENAX THERAPEUTICS, INC.
Revenue
—
FY2025
Operating income
-$56.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API